Guidance Document: Tamper-resistance Formulations of Opioid Drug Products (French, HTML)
Guidance Document: Tamper-resistance Formulations of Opioid Drug Products: French HTML file. From Health Canada, updated Jul 2021. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2021-07-07
This guidance document is specific to the "tamper-resistance" feature of controlled-release opioid products. It is intended for the pre-market review of drug submissions when sponsors seek to obtain approval for controlled-release opioid drug formulations with tamper-resistant properties and wish to include, in product monographs, scientific statements and claims regarding tamper-resistance.
Data overview
- Formats
- HTML
- File languages
- French
- Available actions
- Access original file